Swedish science at the world’s largest biotech convention

PRESS INVITATION 7 May 2009

Swedish science at the world's largest biotech convention

Meet Dr Jonas Frisén, one of the most successful scientists within stem cell research, at an R&D session in the world's largest convention for biotech and pharmaceuticals, BIO 2009 in Atlanta, USA. The session is arranged by the Swedish medical university Karolinska Institutet, SwedenBIO and Invest in Sweden Agency.

Dr. Frisén will talk about stem cell research, currently one of the most exciting areas in science, and how it unravels potential new therapies for Parkinson's, Alzheimer's, spinal cord injury, stroke, heart diseases and other devastating diseases.

He is also the scientific founder of NeuroNova, a biopharmaceutical company, developing stem cell-based therapies for neurological disorders in the central nervous system. NeuroNova has two drug candidates in clinical development, one for Parkinson's disease and one for ALS.

The session will be chaired by Ceci Connolly, National Healthcare Reporter at Washington Post.

R&D session at BIO 2009 - Breaking new stem cell research unlocks unknown therapies

Time: Thursday 21 May at 10:30 am.

Location: Georgia World Congress Center, Room B308, Atlanta.
Key Speaker: Jonas frisén, M.D., Ph.D., Tobias Foundation Professor of Stem Cell Research, Karolinska Institutet, Sweden.
Speaker: Lilian Wikström, Ph.D., Head of Research, NeuroNova AB.
Chair: Ceci Connolly, National Healthcare Reporter, Washington Post.

For more information, please contact:

Sabina Bossi, Press Officer, Karolinska Institutet
Tel: +46-(0)8-524860 66 or +46-(0)70-614 60 66
Email: sabina.bossi@ki.se

Anna Karin Källén, Head of Communications, SwedenBIO,
The Swedish Life Science Industry Organization
Tel: + 46 (0) 8 21 31 32or +46 (0) 734 33 20 85
Email: annakarin.kallen@swedenbio.com